Peter Simmonds@Simmonds_Lab
23 Jun 2024United Kingdom
United KingdomConnected via WebAccount-level information, not a live location or per-post device.
Here is my re-visiting of the C->U hypermutation phenomenon in SARS-CoV-2 genome 4 years from the start of the COVID pandemic:
tinyurl.com/mw3ezp6c
A trajectory of loss of C's / gain of U's, but weak 5' context effect and RNA structure dependence on edited sites. APOBEC 3A??
Peter Simmonds@Simmonds_Lab
19 Feb 2023United Kingdom
United KingdomConnected via WebAccount-level information, not a live location or per-post device.
Replying to @AdrianJ44426152 @simroux_virus
The downloadable ICTV Virus Metadata Resource contains information of virus names and the taxon they are assigned to:
ictv.global/vmr
As an example, here is the listing for members of the genus Hepacivirus. Is this what you meant?
Peter Simmonds@Simmonds_Lab
2 Jun 2021United Kingdom
United KingdomConnected via WebAccount-level information, not a live location or per-post device.
Very experimental but also very surprising, here is some evidence for excess C->U changes in a range of mammalian RNA viruses, potentially related to the much discussed phenomenon in SARS-CoV-2:
doi.org/10.1371/journal.ppat…
Consequences for virus evolution: interesting.....
Peter Simmonds@Simmonds_Lab
22 Apr 2021United Kingdom
United KingdomConnected via WebAccount-level information, not a live location or per-post device.
Job available on Oxford: 1 year post-doc investigating neutralising antibody responses to SARS-CoV-2 infections, serological assay comparisons and their application for COVID plasma and immune Ig treatment. Training in BSL3 working provided - contact [email protected]
Peter Simmonds@Simmonds_Lab
5 Mar 2021United Kingdom
United KingdomConnected via WebAccount-level information, not a live location or per-post device.
Some interesting new data on SARS-CoV-2 B.1.1.7 infections from @jeremyratcliff and the lab, @HarvalHeliand & UK REMAP-CAP team
medrxiv.org/content/10.1101/…
Compared to WT, B.1.1.7 shows no intrinsic replication advantage but viral loads remain high even after Ab seroconversion
Peter Simmonds@Simmonds_Lab
10 Feb 2021United Kingdom
United KingdomConnected via WebAccount-level information, not a live location or per-post device.
One of the fascinating implications of the model is how it redates the LCA of HCV to >300,000 BP before humans' Out-of-Africa migration. Maybe HCV did evolve within humans - genotype distributions may partly reflect geograhical /migrational separations
doi.org/10.1101/2021.02.09.4…
Peter Simmonds@Simmonds_Lab
10 Feb 2021United Kingdom
United KingdomConnected via WebAccount-level information, not a live location or per-post device.
Great to see Mahan @Mahan_Ghafari, Aris Katzourakis's @ArisKatzourakis brilliant PhD student taking on ideas in the Prisoner of War model of virus evolution and putting them into a mathematical framework:
doi.org/10.1101/2021.02.09.4…
Vastly expanded evolutionary time frames.....
Peter Simmonds@Simmonds_Lab
17 Dec 2020United Kingdom
United KingdomConnected via WebAccount-level information, not a live location or per-post device.
I don't think persistent replication of SARS-CoV-2 directly causes "long COVID":
ons.gov.uk/news/statementsan…
but clearly COVID-19 isn't a typical respiratory infection either. See our review of prolonged infections and mechanisms:
microbiologyresearch.org/con…
Peter Simmonds@Simmonds_Lab
4 May 2020United Kingdom
United KingdomConnected via WebAccount-level information, not a live location or per-post device.
Recent analysis of SARS-CoV-2:
- Rampant C->U transitions
- high rates of non-synonymous change
- a mutational process likely driven by the host
- APOBEC-like context
- Potential widespread homoplasy
doi.org/10.1101/2020.05.01.0…
Spock: It's evolution, Jim, but not as we know it
Peter Simmonds@Simmonds_Lab
10 Apr 2020United Kingdom
United KingdomConnected via WebAccount-level information, not a live location or per-post device.
A low seroprrevalence of SARS-CoV-2 in Scotland - Only 6 from 1000 blood donors screened between the 15th - 23rd March were reactive in pseudotype assay or anti-spike protein ELISA. A great team effort to get this data out